Lupin and Sino Universal Pharmaceuticals sign license and supply agreement for tiotropium DPI in China
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
The company received one observation in the Form-483
The collaboration furthers AstraZeneca’s presence in China following the $2.5bn investment in Beijing
The company received 1 (One) observation in the Form-483
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
The acquisition sets up the foundation for a central hub of GMP value-added services and greater access to new customers in the rapidly growing Biopharma market
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
Subscribe To Our Newsletter & Stay Updated